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Abstract 
To evaluate the bacteria belonging to genus Pseudomonas sp, Staphylococcus sp E.coli, 
Klebsiella sp obtained from various clinical Samples (urine, blood, pus, and catheter) 
obtained from diagnostics labs and hospitals of Madurai were screened for their multi 
drug resistance using standard antibiotics such as Ampicillin trihydrate (A), 
Chloramphenicol (C), Gentamycin (G), Tetracycline hydrochloride (T). Ampicillin (A), 
Ceftazidime(CA), Amikacin(AK), Levofloxacin(LE), Cefuroxime(CU), Co-
trimoxazole(CO),   Nalidixic acid (NA), Streptomycin (S), antibiotics with the National 
committee for clinical laboratory standard (NCCLS) new interpretive criteria. The 
isolates that were showing multi drug- resistance were further evaluated for polymerase 
chain reaction PCR as a gold standard method to evaluate the resistant gene by the 
method, Muller Hinton agar (disc diffusion method).  The results showing Multidrug 
resistant gene that has as vehicles for transmission of genetic information involved in 
spread of antibiotic resistance into various species, and to analyze the gene possessing 
the features of MDR using PCR amplification of suspected genes associated with 
resistance production.  
 
1. Introduction 
The term “Antibiotic” refers to any agent that 
has the biological activity against living organism, 
which was originally developed to treat human 
infectious diseases. The antibiotics can be classified 
as either bactericidal or bacteriostatic. Bactericidal 
kills the bacteria directly, where the bacteriostatics 
prevents the bacteria from dividing. The broad use 
of antibiotics had created a strong selective pressure, 
which consistently had resulted in the survival and 
spread of resistance that has evolved with the 
increased number, volume and diversity of 
antimicrobial applications. (Baquero et al., 2003)   
Bacteria are able to inherit antibiotic resistant 
genes to provide protection against most antibiotics. 
The dissemination of antibiotic genes by horizontal 
gene transfer has led to the rapid emergence of 
antibiotic resistance among bacteria (Barlow et al., 
2004). The rapid dissemination of drug-resistant 
bacteria is an alarming and increasing problem, 
complicating the treatment of infections. Much of 
the problem is the result of antibiotic resistant 
genes transferring among bacterial species, carried 
by plasmids and transposons (Stokes et al., 1989). 
Multi- drug resistance bacteria need new 
approaches to the management and treatment of 
infections in hospitalized patients. According to 
them the health care associated infection cause 
substantial resistance and which requires a 
multidisciplinary approach and closer collaboration 
among health care members in hospitals, 
pharmamacist, infection control practitioners and 
infectious disease specialists. They can reduce the 
treatment failures and minimize the spread of 
multidrug- resistance organisms between the 
hospital environment and the community. 
The emergence of antimicrobial resistance 
pathogens now treats the discovery of potent 
antimicrobial agents. Antimicrobial resistance has 
resulted in increased morbidity and mortality as 
well as health care costs. Yearly expenditures arising 
from drug resistance in the United States are $4 
billion and are rising (Archibald et al., 2007). 
The tremendous therapeutic advantage 
afforded by antibiotics is being treated by the 
emergence of increasing the resistance strains of 
microbes. Selective pressure favoring resistant 
strains arises from misuse and over use of 
antibiotics (Thomas et al., 1999). 
The emergence of antibiotic resistance is an 
evolutionary process that is based on selection for 
organism that has enhanced ability to survive. Dose 
of antibiotic that would previously be lethal 
(Cowntey et al., 2008).  
The evolution of antibiotic resistance in 
bacteria is a topic of major medical importance. 
Evolution is the result of natural selection ratting 
on variant phenotypes. Both the rigid base 
sequence of DNA and the more plastic expression 
patterns of the genes present define phenotype. 
Evolution requires phenotypic variation, selection 
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and heritability. It is generally assumed that 
mutation provides the single source of biological 
diversity that fuels evolution (Motce et al., 2008) 
The change in the genetic composition of an 
organism may occur by 1 or 2 mechanisms there 
may be a acquisition of new genetic material 
mutations are generally uncommon events, perhaps 
occurring at a frequency of 1 event per 107 – 1010 
bacteria, but may result in the development of 
resistant during therapy in organisms that are 
initially susceptible (Michael et al., 2009).  
 This work broadly gives knowledge about the 
role of Multidrug resistant gene that has as 
vechicles for transmission of genetic information 
involved in spread of antibiotic resistance into 
various species, and to analyze the gene possessing 
the features of MDR using PCR amplification of 
suspected genes associated with resistance 
production. 
 
2. Materials and Methods 
Collection of clinical isolates 
Clinical isolates were obtained from meenakshi 
mission hospital, Madurai and Bose Clinical 
laboratory, Madurai. 
 
Clinical samples used 
 Blood, Pus, Catheter, Urine etc from UTI 
(Urinary Tract infection) patients. 
 
Glassware and media sterilization 
The glassware were washed thoroughly in 
running tap water, rinsed in distilled water and 
dried in a hot air oven (Yarco hot air sterilizer 1-
431 max temb-200°c (New Delhi). Media were 
sterilized in a portable autoclave (Equitron, 
Mumbai) at 121° C and at 15 lbs pressure for 15 
minutes. All the incubation works were carried out 
under aseptic condition in a Laminar Air flow 
chamber (Atlantis – clear air). Incubation of all 
culture was kept in an incubator (NSW – 150 max 
temp- 60°C, New Delhi). 
 
Processing of samples   
About 100 Clinical samples were collected 
from UTI patients over a 3-month period. The 
strains were isolated and plated. The isolated 
bacteria were collected on tryptone agar slants, and 
were purified twice on MacConkey’s agar. They 
were later maintained on tryptone agar slants. Most 
bacteria were already identified at source, however 
if needed, identification was carried out by 
biochemical reactions and by the reaction on T.S.I 
medium. The Bacterial isolates obtained were 
belonging to the groups E.coli, Pseudomonas sp, 
Klebsiella sp, Staphylococcus sp.  
 
Antibiotics 
The antibiotics used were: Ampicillin trihydrate 
(A), Chloramphenicol (C), Gentamycin (G), 
Tetracycline hydrochloride (T). Ampicillin (A), 
Ceftazidime(CA), Amikacin (AK)    Levofloxacin 
(LE),   Cefuroxime(CU),   Co-trimoxazole(CO),   
Nalidixic acid (NA), Streptomycin (S), (May and 
Baker, Nigeria). The control strains were run 
simultaneously with the test organisms. Results 
were interpreted with the National Committee for 
Clinical Laboratory Standards now known as 
Clinical Laboratory Standard Institute (CLSI) 
criteria for disk diffusion (NCCLS, 2000). All the 
antibiotics were obtained from Sigma Chemical 
Company, U.S.A. 
 
Preservation of isolates 
Glycerol stocks were prepared and stored at -
80oC for long term preservation. Pure cultures 
strains were incubated at 50°C for 48 h in isolation 
broth. Then 0.5 ml of each of the cultures were 
transferred into cryotubes and 0.5 ml broth 
containing 40% glycerol was added. The samples 
were mixed gently and stored at -80°C. 
 
Susceptibility testing 
Antibiotic susceptibility (of both the clinical 
isolates and the Escherichia coli transconjugants) was 
calculated by the disk diffusion method on Mueller-
Hinton (MH) agar according to NCCLS (National 
Committee for Clinical Laboratory Standards, USA) 
recommendations. Antimicrobial agents tested were 
Ampicillin trihydrate (A), Chloramphenicol(C), 
Gentamycin(G),Tetracycline hydrochloride (T), 
Ceftazidime(CA),, Amikacin (AK), Levofloxacin 
(LE), Cefuroxime (CU),Co-trimoxazole(CO), 
Nalidixic acid (NA), Streptomycin (S), (May and 
Baker, Nigeria). The minimum inhibitory 
concentration (MIC) of selected aminoglycosides 
was then determined by the agar dilution technique 
on MH agar plates with an inoculum of 104 CFU 
per spot according to NCCLS recommendations.  
 
Curing of plasmids 
For studying curing by acridine orange, the 
bacterium bearing R plasmid was grown overnight 
in L.B. broth. To the fresh L.B. broth was prepared 
containing 120 µg/ml of acridine orange was 
inoculated with the overnight culture to give a 100 
fold dilution. All this work was carried out in the 
dark because of the light sensitivity of acridine 
orange. A control tube lacking acridine orange was 
always included. The test & the control cultures 
were incubated overnight at 37°C. The test culture 
& the control culture were then diluted & plated on 
MacConkey’s Agar plates, to obtain isolated 
colonies. The colonies from each plating were 
M. Subhathra et al.                                                                                            Journal of  Ecobiotechnology 2/5: 60-64, 2010 
 
grided onto MacConkey’s Agar plates and Nutrient 
agar plates. After overnight incubation at 37°C, 
these were replicated on antibiotic containing plates 
to check for the loss (or its absence) of antibiotic 
resistance determinants. Plasmid DNA were 
extracted by the method (Kado and Liu), Subjected 
to Electrophoresis through agarose 0.8% gel, 
stained with ethidium bromide, photographed 
under UV transillumonator.  
 
Transformation of resistant plasmid 
Extraction of Total DNA of E. coli was 
extracted using Genomic DNA Extraction kit 
(Promega, USA) following manufacture’s protocol 
for Gram-negative bacteria. The PCR solution was 
composed of 10 × buffer 2 µl, dNTPs (2.5 mM) 0.4 
µl, 5’CS/3’CS (10 pmol/ µl) 0.5 µl each, Taq DNA 
polymerase (5 U/ µl, Promega, USA) 0.2 µl, 
distilled water 15.4 µl and template DNA (50 ng/ 
µl) 1 µl. Amplification consisted of an initial 
denaturation at 94oC for 3 min, followed by 30 
cycles of denaturation at 94oC for 30 s, annealing at 
60oC for 30s, and extension at 72oC for 2 min 30s 
and a final extension at 72oC for 5 min. Amplicons 
were analyzed through electrophoresis on 1.0% 
agarose gels, and 1 kb ladder (Takara, Japan) was 
used as a molecular size marker. 
 
3. Results 
The clinical isolates were collected from 
various clinical Samples (urine, blood, pus, and 
catheter) obtained from diagnostics labs and 
hospitals of Madurai, processed and characterized 
for the characterization of Morphological, 
biochemical characters of the isolates, the results 
evaluated belonging to the genus Pseudomonas sp, 
Staphylococcus sp E.coli, Klebsiella sp. The isolates were 
further identified for the resistance pattern by 
performing antibiotics susceptibility test, disc 
diffusion method using standard antibiotics such as 
Ampicillin trihydrate (A), Chloramphenicol (C), 
Gentamycin (G), Tetracycline hydrochloride (T). 
Ampicillin (A), Ceftazidime (CA), Amikacin (AK)    
Levofloxacin (LE),   Cefuroxime (CU),   Co-
trimoxazole (CO),   Nalidixic acid (NA), 
Streptomycin (S), using control organisms and 
antibiotics with the National committee for clinical 
laboratory standard (NCCLS) new interpretive 
criteria. The results showing Multidrug resistant 
gene that has as vehicles for transmission of genetic 
information involved in spread of antibiotic 
resistance into various species, and to analyze the 
gene possessing the features of MDR using PCR 
amplification of suspected genes associated with 
resistance production. 
 
Fig: 1 Pseudomonas sp 
 
 
 
 
 
 
 
 
 
 
 
Fig: 2 E.coli 
 
 
 
 
 
 
 
 
 
Fig: 3 Staphylococcus sp                 
 
 
 
 
 
 
 
Fig: 4 Klebsiella sp 
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Graph: I Antibiotic sensitive / resistance pattern of the clinical isolates and their percentage of resistance for Klebsiella sp, 
Pseudomonas sp, E.coli, Staphylococcus sp 
 
 
 
 
 
 
 
 
 
 
 
 
 
                 
 
 
Plate: a E.coli 
    
 
 
 
 
 
 
 
 
 
Plate: b Pseudomonas sp 
 
 
 
 
 
 
 
 
 
 
    Fig: a Agarose gel  
 
 
 
 
 
 
 
 
 
Transformation: Blue White Selection- Host 
cell: E.coli DH5α; Resistant Plasmids Plate: a and 
Plate: b. Fig a: Agarose gel: 0.8% Showing results of 
Plasmid DNA for isolates 
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